Dr. Ayed O Ayed , MD
Internal Medicine - Hematology & Oncology • Jacksonville, FL
2 Shircliff Way Ste 800
Jacksonville, FL 32204
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Ayed Ayed is listed in NPPES under Internal Medicine - Hematology & Oncology.
-
NPI assigned on September 5, 2012; this date does not establish years in practice.
-
Published CMS data list 22,065 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1439 — Injection, ferric carboxymaltose, 1 mg: 16,500 service units.
- J0897 — Injection, denosumab, 1 mg: 1,200 service units.
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg: 980 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 22 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,398 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Eliquis (Apixaban) — 170 prescription fills, including refills.
- Ondansetron Hcl — 93 prescription fills, including refills.
- Dexamethasone — 78 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 44 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 74 clinicians with data). Median for this group: 16,105. Middle half: 558 to 60,209.
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 540 clinicians with data). Median for this group: 676. Middle half: 294 to 3,798.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,187 in 2020 to 22,065 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2 Shircliff Way Ste 800
Jacksonville, FL 32204
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Cancer Specialists Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2011
What Public CMS Data Show
Internal Medicine - Hematology & Oncology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
304 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $176,977 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $141,553 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,153 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,672,483 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $858.28 across 42 records.
By nature of payment
- Food and Beverage: $858.28 across 42 records.
Reporting-company totals (3 largest of 15)
- Pfizer Inc.: $222.49 across 15 records.
- Janssen Pharmaceuticals, Inc: $117.32 across 1 record.
- Agios Pharmaceuticals, Inc.: $81.70 across 3 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
15 years (graduated 2011)
CMS Doctors and Clinicians data list 2011 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2012
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Ayed has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ayed as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Jacksonville and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 74 clinicians with data). Median for this group: 16,105. Middle half: 558 to 60,209.
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 540 clinicians with data). Median for this group: 676. Middle half: 294 to 3,798.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 74 clinicians with data). Median for this group: $160,461. Middle half: $58,600 to $1,104,562.
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 540 clinicians with data). Median for this group: $65,704. Middle half: $32,030 to $149,760.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 74 clinicians with data). Median for this group: $128,205. Middle half: $45,493 to $872,512.
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 540 clinicians with data). Median for this group: $49,744. Middle half: $23,566 to $115,566.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 85 clinicians with data). Median for this group: 304. Middle half: 115 to 603.
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 550 clinicians with data). Median for this group: 421. Middle half: 147 to 927.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Jacksonville, FL (2024, 85 clinicians with data). Median for this group: $536,804. Middle half: $25,251 to $1,357,269.
A higher Part D drug cost than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Florida (2024, 550 clinicians with data). Median for this group: $1,033,200. Middle half: $175,712 to $2,648,453.
119 active clinicians are listed under Internal Medicine - Hematology & Oncology with a practice address in Jacksonville, FL (831 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Jacksonville
47.9% of these 119 clinicians have the CMS telehealth indicator.
68.1% of these 119 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 257% from 6,187 in 2020 to 22,065 in 2024.
- 2020: 6,187
- 2021: 22,131
- 2022: 24,233
- 2023: 30,225
- 2024: 22,065
-
Medicare-allowed amount
Medicare-allowed amount increased 10% from $161,309 in 2020 to $176,977 in 2024.
- 2020: $161,309
- 2021: $215,487
- 2022: $191,007
- 2023: $219,095
- 2024: $176,977
-
Paid by Medicare
Paid by Medicare varied from year to year: $131,507 in 2020 and $141,553 in 2024.
- 2020: $131,507
- 2021: $177,534
- 2022: $149,686
- 2023: $174,269
- 2024: $141,553
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 121% from 634 in 2020 to 1,398 in 2024.
- 2020: 634
- 2021: 726
- 2022: 874
- 2023: 882
- 2024: 1,398
-
30-day fills
30-day fills increased 138% from 905 in 2020 to 2,153 in 2024.
- 2020: 905
- 2021: 1,080
- 2022: 1,312
- 2023: 1,360
- 2024: 2,153
-
Part D drug cost
Part D drug cost increased 174% from $1,338,548 in 2020 to $3,672,483 in 2024.
- 2020: $1,338,548
- 2021: $1,705,616
- 2022: $1,388,191
- 2023: $873,785
- 2024: $3,672,483
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 92% from $28,897.35 in 2021 to $2,381.78 in 2025.
- 2021: $28,897.35
- 2022: $20,319.15
- 2023: $38,223.12
- 2024: $10,964.38
- 2025: $2,381.78
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 44 records totaling $2,381.78.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Genentech, Inc. |
General
In-kind items and services
|
Lunsumio | Research | $939.17 |
| Genentech, Inc. |
General
In-kind items and services
|
Lunsumio | Research | $584.33 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TECVAYLI | General | $117.32 |
| Tempus AI, Inc |
Food and Beverage
In-kind items and services
|
XT CDX | General | $29.07 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $28.37 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELREXFIO | General | $28.36 |
| Agios Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PYRUKYND | General | $27.89 |
| Agios Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PYRUKYND | General | $27.81 |
| Tempus AI, Inc |
Food and Beverage
In-kind items and services
|
XT CDX | General | $27.68 |
| Agios Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PYRUKYND | General | $26.00 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $25.32 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $24.21 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ADCETRIS | General | $23.61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $22.24 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Venclexta | General | $21.86 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Enhertu | General | $21.40 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
BRAFTOVI | General | $21.32 |
| Geron Corporation |
Food and Beverage
In-kind items and services
|
RYTELO | General | $20.60 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Lenvima | General | $19.71 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
LUMAKRAS | General | $19.46 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
SCEMBLIX | General | $19.35 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELREXFIO | General | $18.13 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TALVEY | General | $18.00 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Enhertu | General | $17.72 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $16.62 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1439
Injection, ferric carboxymaltose, 1 mg
|
16,500 | 13 | $3.82 | $1.09 |
|
J0897
Injection, denosumab, 1 mg
|
1,200 | 13 | $65.70 | $25.60 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
980 | 17 | $1.74 | $0.11 |
|
36415
Insertion of needle into vein for collection of blood sample
|
673 | 206 | $19.13 | $8.65 |
|
J1626
Injection, granisetron hydrochloride, 100 mcg
|
640 | 16 | $5.56 | $0.32 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
588 | 192 | $20.45 | $7.60 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
353 | 172 | $254.49 | $124.17 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
263 | 28 | $62.65 | $26.64 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
231 | 25 | $281.04 | $120.79 |
|
M0010
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
|
106 | 16 | $70.85 | $71.37 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
80 | 64 | $34.00 | $16.08 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
77 | 43 | $162.38 | $77.04 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
64 | 35 | $129.06 | $58.83 |
|
96372
Injection of drug or substance under skin or into muscle
|
64 | 29 | $40.47 | $13.68 |
|
J1200
Injection, diphenhydramine hcl, up to 50 mg
|
54 | 12 | $2.76 | $0.82 |
|
96375
Injection of additional new drug or substance into vein
|
38 | 14 | $50.68 | $14.42 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
35 | 35 | $335.91 | $163.28 |
|
96361
Infusion into a vein for hydration, each additional hour
|
32 | 11 | $35.88 | $11.69 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
32 | 31 | $354.47 | $169.23 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
20 | 16 | $354.50 | $175.89 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
20 | 20 | $270.00 | $128.33 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
15 | 15 | $183.73 | $88.23 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Eliquis | Apixaban | 170 | 7,610 | $146,177.34 | 43 |
| Ondansetron Hcl | Ondansetron Hcl | 93 | 1,070 | $831.04 | 49 |
| Dexamethasone | Dexamethasone | 78 | 1,897 | $933.64 | 30 |
| Gabapentin | Gabapentin | 68 | 3,480 | $766.32 | 19 |
| Olanzapine | Olanzapine | 62 | 3,001 | $638.66 | 30 |
| Letrozole | Letrozole | 59 | 4,680 | $1,251.88 | 18 |
| Anastrozole | Anastrozole | 54 | 4,750 | $956.91 | 21 |
| Revlimid | Lenalidomide | 52 | 1,225 | $783,268.40 | — |
| Prednisone | Prednisone | 50 | 1,420 | $272.14 | 17 |
| Valacyclovir | Valacyclovir Hcl | 48 | 3,900 | $3,036.24 | 19 |
| Lenalidomide | Lenalidomide | 40 | 994 | $527,369.44 | — |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 38 | 916 | $1,543.86 | 29 |
| Pomalyst | Pomalidomide | 36 | 1,001 | $810,016.44 | — |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 33 | 858 | $422.12 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 29 | 727 | $851.83 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 29 | 765 | $535.69 | — |
| Allopurinol | Allopurinol | 28 | 1,589 | $278.91 | 14 |
| Alprazolam | Alprazolam | 28 | 840 | $464.06 | — |
| Hydroxyurea | Hydroxyurea | 25 | 2,232 | $963.32 | — |
| Xarelto | Rivaroxaban | 23 | 1,950 | $34,288.38 | — |
| Warfarin Sodium | Warfarin Sodium | 22 | 960 | $97.25 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 20 | 1,020 | $133.86 | 11 |
| Levothyroxine Sodium | Levothyroxine Sodium | 18 | 1,260 | $129.67 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 1,262 | $98.82 | — |
| Azithromycin | Azithromycin | 17 | 474 | $256.91 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-07-10NUCC Taxonomy Code: 207RH0003X
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20180713000546
FL
6002058625
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Cancer Specialists Llc
725 Skymarks Dr, Jacksonville, FL 322187248
Phone: 9043672611
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Radiology - Radiation Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Registered Nurse Practitioner
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 7751 BELFORT PKWY STE 350, JACKSONVILLE, FL 322566951 (Tel: 9043637453)
Registered at 2 SHIRCLIFF WAY STE 800, JACKSONVILLE, FL 32204 (Tel: 9043882619)
Registered at 7015 A C SKINNER PKWY STE 1, JACKSONVILLE, FL 322566932 (Tel: 9043632113)
Internal Medicine (license number reported to NPPES: FL ME135547)
NPI status registered as active in NPPES database
Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)
Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)
Recorded as AYED AYED, M.D.
Internal Medicine (license number reported to NPPES: MN 59066)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Hematology & Oncology Specialists in Jacksonville
- Dr. Hemant Murthy, MD
- Dr. Winston Tan, MD
- Dr. Ricardo Parrondo, MD
- Dr. Sahana Kalmadi, MD
- Dr. Richard Joseph, MD
- Dr. Jennifer Miatech, MD
Mailing Address
7751 Belfort Pkwy Ste 350
Jacksonville, FL 322566951
Phone: 9043637453